On the recordDecember 1, 2022
Madam President, I ask unanimous consent that the committee-reported substitute amendment be withdrawn; that the McConnell substitute amendment at the desk be agreed to; that the bill, as amended, be considered read a third time and passed; and that the motion to reconsider be considered made and laid upon the table. The ACTING PRESIDENT pro tempore. Without objection, it is so ordered. The committee-reported amendment in the nature of a substitute was withdrawn. The amendment (No. 6504) in the nature of a substitute was agreed to, as follows: Strike all after the enacting clause and insert the following: SECTION 1. SHORT TITLE. This Act may be cited as the ``Cardiovascular Advances in Research and Opportunities Legacy Act''. SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES. (a) In General.--The Secretary of Health and Human Services (referred to in this section as the ``Secretary'') shall, as appropriate, continue activities related to research, education, and awareness of valvular heart diseases. (b) NIH Research Related to Valvular Heart Diseases.-- (1) In general.--The Director of the National Institutes of Health, in consultation with the Director of the National Heart, Lung, and Blood Institute, may support or conduct research regarding valvular heart diseases.…





